These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 5465951)

  • 1. [Pituitary adrenocortical function in synthetic adrenal cortex steroid therapy, with special reference to the results of alternative day treatment].
    Kaneko K
    Nihon Naibunpi Gakkai Zasshi; 1970 Aug; 46(5):513-25. PubMed ID: 5465951
    [No Abstract]   [Full Text] [Related]  

  • 2. A study of diurnal variation of adrenocortical function and recovery of the functional integrity of pituitary adrenal axis after long term corticosteroid therapy.
    Ghosh P; Taneja RL; Malhotra SC; Kumar V; Ahuja MM
    Indian J Med Res; 1974 Feb; 62(2):246-53. PubMed ID: 4442967
    [No Abstract]   [Full Text] [Related]  

  • 3. The function of the pituitary gland and the adrenal cortex during treatment with glucocorticoids.
    Binder C
    Acta Med Scand Suppl; 1969; 500():71-5. PubMed ID: 4317086
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pituitary-adrenocortical function of women following Gestagen administration].
    Yagi T
    Nihon Naibunpi Gakkai Zasshi; 1967 Jan; 42(10):1098-116. PubMed ID: 4291682
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical studies on the stimulation and suppression of the pituitary-adrenocortical system. II. Studies on the pituitary-adrenocortical suppression test].
    Sako T
    Nihon Naibunpi Gakkai Zasshi; 1968 Dec; 44(9):1016-24. PubMed ID: 4304528
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of reserpine treatment on pituitary-adrenocortical axis in patients with Cushing's disease.
    Minamori Y; Yasuda K; Murayama M; Morita H; Yamakita N; Miura K
    Endocr J; 1993 Oct; 40(5):545-56. PubMed ID: 7951520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical studies on the stimulation and suppression of the pituitary-adrenocortical system. 3. Studies on the pituitary adrenocortical suppression after long-term glucocorticoid treatment].
    Sako Y
    Nihon Naibunpi Gakkai Zasshi; 1968 Dec; 44(9):1025-36. PubMed ID: 4304529
    [No Abstract]   [Full Text] [Related]  

  • 8. [Plasmatic 17-alpha-hydroxyprogesterone in congenital adrenal hyperplasia due to 21 hydroxylase deficiency, treated and untreated].
    Loras B; Roux H; Audi-Parera L; David M; Bertrand J
    Biomedicine; 1974 Jul; 21(7):317-22. PubMed ID: 4373095
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnosis of Cushing's syndrome. The differentiation between adrenocortical hyperplasia and adrenocrotical adenoma by means of lysine-vasopressin.
    Bethge H; Bayer JM; Winkelmann W
    Acta Endocrinol (Copenh); 1969 Jan; 60(1):47-59. PubMed ID: 4308289
    [No Abstract]   [Full Text] [Related]  

  • 10. RU 486: a steroid with antiglucocorticosteroid activity that only disinhibits the human pituitary-adrenal system at a specific time of day.
    Gaillard RC; Riondel A; Muller AF; Herrmann W; Baulieu EE
    Proc Natl Acad Sci U S A; 1984 Jun; 81(12):3879-82. PubMed ID: 6328529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Observations and comments on failure of dexamethasone suppression.
    Linn JE; Bowdoin B; Farmer TA; Meador CK
    N Engl J Med; 1967 Aug; 277(8):403-5. PubMed ID: 4378314
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo effects of 'equipotent' doses of synthetic steroids on lymphocytes and on the pituitary-adrenal system in man.
    Newsome HH; Thomas JM
    Surg Forum; 1977; 28():118-20. PubMed ID: 617391
    [No Abstract]   [Full Text] [Related]  

  • 13. [The corticotropic axis during prolonged treatment with beclomethasone dipropionate in children].
    Dutau G; Rochiccioli P
    Nouv Presse Med; 1977 Apr; 6(15):1315-8. PubMed ID: 866140
    [No Abstract]   [Full Text] [Related]  

  • 14. Temporal rhythm in the response of urinary 17-OHCS to metopirone in Cushing's syndrome due to bilateral adrenal hyperplasia.
    Takebe K
    J Clin Endocrinol Metab; 1973 Mar; 36(3):433-8. PubMed ID: 4685385
    [No Abstract]   [Full Text] [Related]  

  • 15. The rationale of alternate-day corticosteroid therapy.
    Jacobson ME
    Postgrad Med; 1971 Feb; 49(2):181-6. PubMed ID: 4322309
    [No Abstract]   [Full Text] [Related]  

  • 16. Laboratory investigation of the human hypothalamic-pituitary-adrenocortical system.
    Grant JK; Hall PE
    Scott Med J; 1971 Feb; 16(2):157-67. PubMed ID: 4324744
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypothalamic-pituitary-adrenocortical regulation. A contribution to its assessment, development and disorders in infancy and childhood with special reference to plasma cortisol circadian rhythm.
    Zurbrügg RP
    Monogr Paediatr; 1976; 7():1-83. PubMed ID: 177857
    [No Abstract]   [Full Text] [Related]  

  • 18. Corticosteroid-induced suppression of the hypothalamo-pituitary-adrenal axis: observations on patients given oral corticosteroids for rheumatoid arthritis.
    Jasani MK; Boyle JA; Greig WR; Dalakos TG; Browning MC; Thompson A; Buchanan WW
    Q J Med; 1967 Jul; 36(143):261-76. PubMed ID: 6049762
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of multiple courses of antenatal corticosteroids on pituitary-adrenal function in preterm infants.
    Ng PC; Wong GW; Lam CW; Lee CH; Fok TF; Wong MY; Ma KC
    Arch Dis Child Fetal Neonatal Ed; 1999 May; 80(3):F213-6. PubMed ID: 10212084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of high doses of synthetic ACTH on the function of the hypothalamo-hypophyseal-adrenal cortex system].
    Walser A; Barthe P; Schär J
    Schweiz Med Wochenschr; 1968 Nov; 98(48):1892-5. PubMed ID: 4303138
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.